4 completed. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Phenylbutyrates: new trials by email Literature Review of Phenylbutyrates trials Research Report on Phenylbutyrates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis Phenylbutyrate Oral Tablet - Inclusion Body Myositis, Sporadic Inclusion Body Myositis | Phase 1 | Completed | University of Kansas Medical Center | 10 | 2020-08-20 | 2024-09-19 |
| Phenylbutyrate Therapy for Maple Syrup Urine Disease Phenylbutyrate, Placebo powder - Maple Syrup Urine Disease | Phase 2 / Phase 3 | Completed | Brendan Lee | 20 | 2013-02-01 | 2019-03-19 |
| Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors Phenylbutyrate - Brain Tumor | Phase 2 | Completed | National Cancer Institute (NCI) | 120 | 2000-11-01 | 2008-03-04 |
| Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy phenylbutyrate - Brain Neoplasms, Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 35 | 1996-12-01 | 2008-03-04 |
Brain Neoplasms (2) · Maple Syrup Urine Disease (1) · Myositis, Inclusion Body (1) · Neuroblastoma (1)
National Cancer Institute (NCI) (2) · Brendan Lee (1) · University of Kansas Medical Center (1)
United States (4)
Brendan Lee, M.D., Ph.D. (1) · Duaa Jabari, MD (1)